hsa-mir-3652: Breast cancer-associated miRNAs identified in a study included hsa-mir-3652 [PMC4867432]. hsa-mir-3652 was one of the miRNAs selected for validation in another study [PMC6196268]. hsa-mir-3652 was also found to be part of a subnetwork in breast cancer, along with other circRNAs, miRNAs, and mRNAs [PMC7283524]. In the context of COVID-19, hsa-mir-3652 was found to be significantly downregulated in the plasma of patients [PMC9346380]. In the diagnosis of sepsis, hsa-mir-3652 was identified as an ideal target for early-stage detection [PMC9537587]. Differential expression of hsa-mir-3652 was also observed in the infection of K. pneumoniae [PMC9537587]. Additionally, hsa-mir-3652 was highlighted as one of the miRNAs related to sepsis and ygiM expression [PMC9537587]. In a study comparing MMVP specimens and FED samples, higher expression levels of hsa-mir-3652 were found in MMVP specimens [PMC4881574]. Furthermore, hsa-mir-3652 was associated with overall survival in papillary thyroid carcinoma (PTC) patients [PMC8548639]. Finally, five pre-miRNA loops were omitted from a library due to length limitations, including hsa-mir-3652 [PMC7723054].\